HB33

In preliminary provisions, further providing for definitions; in practitioners, further providing for pr actitioner registration; in medical marijuana controls, further providing for electronic tracking and for laboratory; and, in Medical Marijuana Advisory Board, further providing for advisory board.

Chamber Passed·3/17/25

Pennsylvania HB33 amends the Medical Marijuana Act to enhance laboratory testing standards and oversight.

HB33 amends the Medical Marijuana Act to establish stricter testing standards for medical marijuana. It mandates that growers/processors contract with approved laboratories for compliance, stability, and research testing. The bill also allows for audit testing and requires laboratories to report test results to the department. The Department of Health is tasked with approving laboratories, conducting quality assurance testing, and establishing standard operating procedures. The bill creates a Medical Marijuana Advisory Board to oversee these processes and ensure compliance.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the House · 194–8 · Mar 17, 2025
Current
Law & Justice Committee
Next
Senate floor vote

Sponsors

DDDDDDDDDDDDDDD
15
2
RR
Democratic CaucusRepublican Caucus

Roll Call Votes

37 Yea

DDRDDDDRDDRRDRRRDDRDDRDDDRRDDDRDDRDRR

0 Nay

Calendar

Jan 29, 2025

9:30 AM

Health (h) Hearing

History

Mar 17, 2025

House

Re-reported as committed

Mar 17, 2025

House

Third consideration and final passage (194-8)

Mar 17, 2025

Senate

In the Senate